Harbour Capital Advisors LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 9,750 shares of the company's stock, valued at approximately $450,000.
Other hedge funds have also recently made changes to their positions in the company. Private Advisor Group LLC purchased a new position in Tempus AI in the fourth quarter worth $1,344,000. Sigma Planning Corp boosted its holdings in shares of Tempus AI by 43.9% during the fourth quarter. Sigma Planning Corp now owns 33,638 shares of the company's stock worth $1,136,000 after purchasing an additional 10,269 shares during the period. First Horizon Advisors Inc. increased its stake in shares of Tempus AI by 207.9% during the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after buying an additional 1,108 shares during the period. IFP Advisors Inc bought a new position in Tempus AI in the 4th quarter worth $76,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Tempus AI in the 4th quarter worth about $1,615,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Tempus AI
In related news, EVP Andrew Polovin sold 17,552 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.43, for a total value of $1,113,323.36. Following the transaction, the executive vice president now owns 138,877 shares of the company's stock, valued at approximately $8,808,968.11. This trade represents a 11.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Ryan M. Bartolucci sold 6,073 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total transaction of $383,995.79. Following the sale, the chief accounting officer now directly owns 47,799 shares of the company's stock, valued at approximately $3,022,330.77. This represents a 11.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 609,897 shares of company stock worth $41,397,783 over the last quarter. Company insiders own 27.60% of the company's stock.
Tempus AI Stock Up 4.0%
Shares of Tempus AI stock traded up $2.63 on Tuesday, reaching $68.28. The company's stock had a trading volume of 7,737,030 shares, compared to its average volume of 7,110,543. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The firm's fifty day simple moving average is $59.18 and its two-hundred day simple moving average is $52.81. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The company has a market capitalization of $11.82 billion and a price-to-earnings ratio of -8.75.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's revenue for the quarter was up 75.4% on a year-over-year basis. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several analysts have commented on the stock. Piper Sandler raised their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. JPMorgan Chase & Co. lowered Tempus AI from an "overweight" rating to a "neutral" rating and lifted their price target for the company from $50.00 to $55.00 in a research report on Tuesday, February 25th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a report on Wednesday, May 7th. BTIG Research assumed coverage on shares of Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 target price on the stock. Finally, William Blair reiterated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Tempus AI has a consensus rating of "Moderate Buy" and an average target price of $63.42.
Read Our Latest Report on TEM
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
